Program
MI078
A development code. Also written as “MI078 capsule”, “MI078 capsule dose 1” and “MI078 capsule dose 2”.
Its studies are mostly in Depression, Postpartum, led by Nanjing Minova Pharmaceutical.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Nanjing Minova Pharmaceutical | 31 open or running | phase 3since Jul 10, 2026 | Apr 24, 2025 | Dec 2027phase 3 · NCT07721961 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Apr 24, 2025First study: phase 1 study in Depression, PostpartumFirst studyNCT06982651 · 98 enrolled · China
- Apr 28, 2025Phase 2 study in Depression, PostpartumNCT06963580 · 72 enrolled · China
- Jul 10, 2026Phase 3 study in Depression, PostpartumPhase 3 reachedNCT07721961 · 200 planned · China
Ahead
- Dec 2027Primary completion: phase 3 study in Depression, PostpartumNCT07721961
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07721961Depression, Postpartum · China | 3 | Recruiting | Dec 2027 | 200 |
| NCT06963580Depression, Postpartum · China | 2 | Completed | Aug 7, 2025 | 72 |
| NCT06982651Depression, Postpartum · China | 1 | Completed | Mar 18, 2024 | 98 |
How it is read
Names in the registry
- “MI078 capsule”, 1 entry
- “MI078 capsule dose 1”, 1 entry
- “MI078 capsule dose 2”, 1 entry
- “MI078”, 1 entry
Codes read as this program: MI078.
Conditions, from the studies’ own filings
- Depression, Postpartum, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.